Trial intelligence / Profile preview

Adalimumab for refractory chronic urticaria

2010-022705-18Phase 4Completed

Sponsor: OverlÃ¦ge, dr.med. Claus Zachariae
Start: Oct 2010
Modality: Monoclonal Antibodies → Antibody-Based Therapeutics
Countries: 1

Overview

Phase 4, open-label, single-arm trial of adalimumab in chronic urticaria (CU), sponsored by OverlÃ¦ge, dr.med. Claus Zachariae. Primary endpoint: Change in urticaria activity score at week 16. Started Oct 2010; status: completed.

Drugs

adalimumab

Conditions

chronic urticaria (CU)

Beyond the preview

Go deeper on 2010-022705-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-022705-18.